Search

BALTIMORE, (JUNE 12, 2024) – In joining Saul Ewing as a new partner, Carville B. Collins brings the firm’s clients more than 30 years of experience representing energy, water and other regulated businesses seeking a wide array of approvals from Maryland regulators. His practice also includes work in...

On May 14, 2024, Jamie Stevens and Elizabeth Thompson (both in our Chicago office) did a presentation for the Community Association’s Institute Legal Forum, to over 230 community association managers serving the Chicagoland area, including many current client managers. They talked on “What Can I Say...

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

Saul Ewing LLP announced today that it has elected partners Colleen A. Foley and Amy S. Kline to the Firm’s nine-member Executive Committee. Ms. Foley will serve a four-year term, effective immediately. Ms. Kline will serve a five-year term, beginning on January 21, 2023 upon the expiration of...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Steve Malitz and Jamie Stevens of Saul Ewing's Chicago office spoke on " Rules, Insurance and Cost Cutting in Condominium Associations" for CAI in September 2022 with Brian Lozell of Associa.

In July 2022, Jamie Stevens, Counsel in Saul Ewing's Chicago Office and a member of the firm's Condominiums and Community Associations practice, spoke on “The Aftermath of New Fannie Mae Guidelines – Industry Updates, Deferred Maintenance, and Current Trends” for CAI with Anthony Dister of Wintrust...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...